| Literature DB >> 36141991 |
In Young Cho1, Hye Mi Lee1, Sae Yun Kim1, Eun Sun Kim2.
Abstract
This study designed to evaluate the short- and long-term outcomes of outborn and inborn preterm infants enhancing the regional perinatal system in South Korea. It is a prospective cohort study of the Korean neonatal network database for infants born at <29 weeks of gestation between 2013 and 2015. Of 2995 eligible infants, 312 were outborn, and 976 completed the assessment of long-term outcome at 18-24 months of corrected age. The mean gestational age was significantly younger in outborn infants than in inborn infants (p = 0.004). The mean Apgar score at 5 min was higher in inborn infants (p = 0.046). More inborn preterm infants died before discharge (p < 0.001); however, most of the other short-term outcomes occurred significantly more often in outborn infants than in inborn infants. The outborn infants had higher odds of neurodevelopmental impairment (adjusted odds ratio (aOR) 2.412, 95% confidence interval (CI) 1.585-3.670), cerebral palsy (aOR 4.460, 95% CI 2.249-8.845) and developmental impairment (aOR 2.238, 95% CI 1.469-3.408). In preterm infants, the location of birth may be a key factor influencing short- and long-term outcomes. Thus, to provide adequate care and efficiently allocate medical resources to high-risk preterm infants, nationwide regional perinatal systems need to be improved and standardized.Entities:
Keywords: inborn; outborn; perinatal retrieval system; preterm
Mesh:
Year: 2022 PMID: 36141991 PMCID: PMC9517045 DOI: 10.3390/ijerph191811718
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flow chart of inborn and outborn infants from birth to follow-up. Analyzed data (n = 2995: inborn, 2683; outborn, 312) were obtained from the Korean Neonatal Network Database (2013–2015). GA, gestational age; CA, corrected age.
Antenatal and perinatal characteristics.
| Characteristics | Inborn ( | Outborn ( | |
|---|---|---|---|
|
| |||
| Maternal age, years | 32.8 ± 4.2 | 33.0 ± 4.4 | 0.412 |
| Maternal age > 35 y | 630 (23.5%) | 73 (23.4%) | 0.974 |
| Primipara | 1531 (57.1%) | 194 (62.2%) | 0.083 |
| Assisted conception | 595 (22.2%) | 71 (22.8%) | 0.829 |
| Multiple pregnancy | 853 (31.8%) | 103 (33.0%) | 0.662 |
| Maternal Hypertension | 322 (12.0%) | 29 (9.3%) | 0.159 |
| Maternal diabetes | 189 (7.0%) | 14 (4.5%) | 0.089 |
| Oligohydramnios | 342/2424 (14.1%) | 33/256 (12.9%) | 0.593 |
| Any antenatal steroid | 2109/2652 (79.5%) | 229/289 (79.2%) | 0.909 |
| Chorioamnionitis | 992/2268 (43.7%) | 111/232 (47.8%) | 0.238 |
| Premature rupture of membrane | 544/2617 (20.8%) | 91/289 (21.1%) | 0.899 |
| Delivered by Caesarian section | 1911 (71.2%) | 210 (67.3%) | 0.150 |
|
| |||
| Birth weight, gram | 907.1 ± 246.1 | 885.2 ± 212.9 | 0.132 |
| Small for gestational age | 215 (8.0%) | 19 (6.1%) | 0.231 |
| Gestational period, week | 264/7 ± 15/7 | 261/7 ± 14/7 | 0.004 |
| Male gender | 1395 (52.0%) | 164 (52.6%) | 0.849 |
| AS, 1 min | 3.8 ± 1.9 | 3.7 ± 1.9 | 0.390 |
| AS, 5 min | 6.1 ± 1.9 | 5.9 ± 1.9 | 0.046 |
| AS < 7 at 5 min | 1330/2668 (49.9%) | 168/305 (55.1%) | 0.083 |
| BT at admission | 36.0 ± 0.7 | 36.0 ± 0.7 | 0.645 |
| pH at admission | 7.26 ± 0.12 | 7.25 ± 0.14 | 0.728 |
Values are numbers (percentages) for categorical variables and means ± standard deviations, as appropriate. p-values comparing inborn and outborn infants by using chi-square test or Fisher’s exact test for categorical variables and Student’s t-test or Wilcoxon rank sum test for continuous variables. AS, Apgar score; BT, body temperature.
The short-term neonatal outcome.
| Characteristics | Inborn ( | Outborn ( | aOR (95% CI) | |
|---|---|---|---|---|
| Total number of infants admitted to NICU | 2683 | 312 | - | - |
| Mortality before discharge | 625/2683 (23.3%) | 12/312 (3.8%) | 0.073 (0.039, 0.138) | <0.001 |
| RDS | 2585/2683 (96.3%) | 302/312 (96.8%) | 1.098 (0.546, 2.209) | 0.794 |
| Sepsis | 628/2676 (23.5%) | 123/311 (39.5%) | 1.891 (1.482, 2.412) | <0.001 |
| PDA, requiring surgical treatment | 433/2642 (16.4%) | 102/312 (32.7%) | 2.436 (1.872, 3.169) | <0.001 |
| Severe brain injury | 558/2523 (22.1%) | 100/310 (32.3%) | 1.510 (1.154, 1.977) | 0.003 |
| IVH grade 3 or 4 | 407/2523 (16.1%) | 76/310 (24.5%) | 1.470 (1.090, 1.982) | 0.012 |
| NEC ≥ 2 | 230/2660 (8.6%) | 60/312 (19.2%) | 2.351 (1.706, 3.239 | <0.001 |
| Moderate-to-severe BPD or death | 1504/2683 (56.1%) | 197/312 (63.1%) | 1.162 (0.886, 1.523) | 0.278 |
| Severe ROP | 527/2134 (24.7%) | 126/298 (42.3%) | 1.606 (1.199, 2.151) | 0.001 |
Values are numbers (percentages) for categorical variables and means (standard deviation), as appropriate. p-values and aOR are calculated using binary logistic regression after adjusting gestational period and 5 min Apgar scores. Some infants do not perform tests before discharge (or death), so there is a difference in the total number of comparisons, indicating the denominator of each variable. NICU, neonatal intensive care unit; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; IVH, intraventricular hemorrhage; NEC, necrotising enterocolitis; BPD, bronchopulmonary dysplasia; ROP, retinopathy of prematurity, aOR, adjusted odds ratio; CI, confidence interval.
The long-term neurodevelopmental outcome.
| Characteristics | Inborn | Outborn | aOR (95% CI) | |
|---|---|---|---|---|
| Mortality after discharge up to follow-up * | 11/2141 (0.5%) | 13/222 (5.9%) | 15.658 (6.840, 35.844) | <0.001 |
| Combined mortality * | 636/2141 (29.7%) | 25/222 (11.3%) | 0.283 (0.172, 0.465) | <0.001 |
| Death or NDI † | 873/1505 (58.0%) | 76/132 (57.6%) | 1.095 (0.739, 1.623) | 0.650 |
| Total number of infants with complete assessment at 18–24 months ‡ | 869 | 107 | ||
| NDI ‡ | 233/869 (26.8%) | 51/107 (47.7%) | 2.412 (1.585, 3.670) | <0.001 |
| Cerebral palsy (GMFCS ≥ 3) ‡ | 28/869 (3.2%) | 15/107 (14.0%) | 4.460 (2.249, 8.845) | <0.001 |
| Developmental impairment ‡ | 230/869 (26.5%) | 48/107 (44.9%) | 2.238 (1.469, 3.408) | <0.001 |
| Visual impairment ‡ | 2/869 (0.2%) | - | 0.712 (0.087, 5.806) | 0.751 |
| Hearing impairment ‡ | 12/869 (1.4%) | 3/107 (2.8%) | 2.157 (0.593, 7.850) | 0.244 |
Values are numbers (percentages). p-Values and aORs are calculated using binary logistic regression after adjusting gestational period and 5 min Apgar scores. Combined mortality includes infants who died before discharge and after discharge. NDI was defined when least one of the following situations were diagnosed: cerebral palsy, developmental impairment, visual impairment or hearing impairment. * Infants with follow-up loss were excluded: 222 outborn and 2131 inborn infants. † Infants who had completed follow-up assessment or confirmed whether alive or dead were included for analyses: 132 outborn and 1505 inborn infants. ‡ Only for infants who had completed follow-up assessment: 107 outborn and 869 inborn infants. NDI, neurodevelopmental impairment; GMFCS, Gross Motor Function Classification System; aOR, adjusted odds ratio; CI, confidence interval.
Baseline characteristics of infants who were not evaluated at 18–24 months of corrected age.
| Characteristics | Infants Included in Analysis | Infants without Follow-Up Data | |
|---|---|---|---|
|
| |||
| Maternal age, years | 33.0 ± 4.2 | 32.6 ± 4.3 | |
| Maternal age > 35 y | 389 (23.8%) | 314 (23.1%) | 0.680 |
| Primipara | 994 (60.7%) | 731 (53.8%) | 0.000 |
| Assisted conception | 401 (24.5%) | 265 (19.5%) | 0.001 |
| Multiple pregnancy | 546 (33.4%) | 410 (30.2%) | 0.065 |
| Maternal Hypertension | 207 (12.6%) | 144 (10.6%) | 0.084 |
| Maternal diabetes | 104 (6.4%) | 99 (7.3%) | 0.310 |
| Oligohydramnios | 235 (16.0%) | 140 (11.5%) | 0.001 |
| Any antenatal steroid | 1275/1605 (79.4%) | 1063/1336 (79.6%) | 0.933 |
| Chorioamnionitis | 610 (44.3%) | 493 (43.9%) | 0.870 |
| Premature rupture of membrane | 332 (20.9%) | 273 (20.7%) | 0.928 |
| Delivered by Caesarian section | 1179 (72.0%) | 942 (69.4%) | 0.112 |
|
| |||
| Birth weight, gram | 850.3 ± 244.5 | 970.5 ± 224.0 | <0.001 |
| Small for gestational age | 164 (10.0%) | 70 (5.2%) | <0.001 |
| Gestational period, week | 260/7 ± 15/7 | 266/7 ± 13/7 | <0.001 |
| Male gender | 843 (51.5%) | 716 (52.7%) | 0.503 |
| Outborn | 132 (8.1%) | 180 (13.3%) | <0.001 |
| AS, 1 min | 3.5 ± 1.8 | 4.1 ± 1.8 | <0.001 |
| AS, 5 min | 5.8 ± 2.0 | 6.4 ± 1.7 | <0.001 |
| AS < 7 at 5 min | 916/1628 (56.3%) | 582/1345 (43.3%) | <0.001 |
| BT at admission | 36.0 ± 0.8 | 36.1 ± 0.6 | <0.001 |
| pH at admission | 7.25 ± 0.13 | 7.27 ± 0.11 | <0.001 |
Values are numbers (percentages) for categorical variables and means (standard deviation), as appropriate. p-values comparing inborn and outborn infants by using chi-square test or Fisher’s exact test for categorical variables and Student’s t-test or Wilcoxon rank sum test for continuous variables. AS, Apgar score; BT, body temperature.
Figure A1The time of death of infants who died during the study period. More than half of inborn infants died within 2 weeks after birth.